Sign Up Today and Learn More About Rivus Pharmaceuticals Stock
Invest in or calculate the value of your shares in Rivus Pharmaceuticals or other pre-IPO companies through EquityZen's platform.
Rivus Pharmaceuticals Stock (RIVP)
Rivus Pharmaceuticals operates as a biopharmaceutical company dedicated to improving cardio-metabolic health.
About Rivus Pharmaceuticals Stock
Founded
2019
Headquarters
Charlottesville, VA, US
Industries
Science and Engineering, Health Care, Biotechnology
Rivus Pharmaceuticals Press Mentions
Stay in the know about the latest news on Rivus Pharmaceuticals
Chutes & Ladders—Sarepta CEO to step down as DM1 hits close to home
fiercebiotech • Feb 28, 2026
Rivus Pharmaceuticals Appoints Jorge Bartolome as Chief Executive Officer
biospace • Feb 25, 2026
Obesity Drugs Market Size 2026 | Analysis, Key Drivers, T...
pharmiweb • Feb 16, 2026
Chutes & Ladders—Moderna CMO steps down in leadership mix-up
fiercebiotech • Feb 12, 2026
Rivus Pharmaceuticals Announces New Data from Phase 2 M-ACCEL Trial of HU6 in MASH in Late-Breaker Oral Presentation at AASLD The Liver Meeting® 2025
globenewswire • Nov 08, 2025
Rivus Pharmaceuticals Management
Leadership team at Rivus Pharmaceuticals
Executive Chairman
Jayson Dallas
Board Member
Francesco Rubertis
Join now and verify your accreditation status to gain access to:
- Rivus Pharmaceuticals Current Valuation
- Rivus Pharmaceuticals Stock Price
- Rivus Pharmaceuticals Management
- Available deals in Rivus Pharmaceuticals and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Rivus Pharmaceuticals Cap Table and Funding History by Share Class and Liquidity Preferences
- Rivus Pharmaceuticals Revenue and Financials
- Rivus Pharmaceuticals Highlights
- Rivus Pharmaceuticals Business Model
- Rivus Pharmaceuticals Risk Factors
- Rivus Pharmaceuticals Research Report from SACRA Research
Trading Rivus Pharmaceuticals Stock
How to invest in Rivus Pharmaceuticals stock?
Accredited investors can buy pre-IPO stock in companies like Rivus Pharmaceuticals through EquityZen funds. These investments are made available by existing Rivus Pharmaceuticals shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell Rivus Pharmaceuticals stock?
Shareholders can sell their Rivus Pharmaceuticals stock through EquityZen's private company marketplace. EquityZen's network includes over 430K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 52K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
